Constipation News and Research

Latest Constipation News and Research

Antidepressant amitriptyline shown to alleviate symptoms of irritable bowel syndrome

Researchers at Mattel Children's Hospital UCLA have found that low-dose antidepressant therapy can significantly improve the overall quality of life for adolescents suffering from irritable bowel syndrome (IBS).

1 May 2008

FDA approves Amitiza for irritable bowel syndrome with constipation

The U.S. Food and Drug Administration today approved Amitiza (lubiprostone) for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in adult women aged 18 and over.

29 Apr 2008

FDA approves Relistor for opioid-induced constipation - helps reduce effects of drugs like morphine on bowel function

The U.S. Food and Drug Administration today approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients with late-stage, advanced illness who are receiving opioids on a continuous basis to help alleviate their pain.

24 Apr 2008

Black women less likely to develop urinary incontinence than white women

The good news for black women: They have less than half the chance of developing urinary incontinence as do white women, according to a new study from the University of Michigan Health System.

22 Apr 2008

Dopamine agonists reduce motor complications in Parkinson's disease, but increase other side-effects

Dopamine agonists are increasingly used to treat people with Parkinson's disease, but there is a debate about how well they work.

17 Apr 2008

Myth about drinking copius amounts of water debunked

Scientists in the United States say there is little evidence that drinking lots of water improves the health.

3 Apr 2008

Smell impairment can precede the development of Parkinson's disease in men

Impaired sense of smell occurs in the earliest stages of Parkinson's disease (PD) and there is mounting evidence that it may precede motor symptoms by several years, although no large-scale studies had confirmed this.

24 Mar 2008

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.

11 Mar 2008

FDA approves Aloxi injection for prevention of postoperative nausea and vomiting

Eisai Corporation of North America, its U.S. subsidiary, MGI PHARMA, INC., and Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved Aloxi (palonosetron hydrochloride) injection for the prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery.

4 Mar 2008

FDA approves PRISTIQ for the treatment of adult patients with major depressive disorder

Wyeth Pharmaceuticals, a division of Wyeth, has announced that the U.S. Food and Drug Administration (FDA) has approved PRISTIQ (desvenlafaxine), a structurally novel, once-daily serotonin-norepinephrine reuptake inhibitor (SNRI), to treat adult patients with major depressive disorder (MDD).

3 Mar 2008

New blood test for early stage ovarian cancer

Australian researchers say they have developed an accurate blood test to detect the first stages of ovarian cancer.

3 Mar 2008

Real-time imaging device may improve surgery for congenital colon disease

Researchers at Cedars-Sinai Medical Center are developing a spectral imaging system that could result in shorter operating times for infants undergoing surgery for Hirschsprung's disease, according to a mouse study reported in the Journal of Biophotonics.

1 Mar 2008

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.

1 Mar 2008

Lilly knocked back by FDA on Zyprexa for schizophrenia treatment

Eli Lilly and Company has received a not approvable letter from the U.S. Food and Drug Administration for Zyprexa long-acting injection (olanzapine LAI) for the treatment and maintenance treatment of schizophrenia in adults, the company announced.

28 Feb 2008

FDA approves Nexium for gastroesophageal reflux disease in children

The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD).

28 Feb 2008

Brain response differences found in way women with irritable bowel syndrome deal with pain

UCLA researchers found that women with IBS cannot effectively turn-off a pain modulation mechanism in the brain, which causes them to be more sensitive to abdominal pain, compared to women without IBS.

9 Jan 2008

Researchers establish risk factors for Parkinson's disease

Doctors know an impaired sense of smell is an early indicator of Parkinson's Disease.

8 Jan 2008

Placebo better than antipsychotic drugs for treating aggression in the intellectually disabled

Antipsychotic drugs which are commonly used to treat aggression in people who are intellectually disabled have been revealed to be ineffective.

6 Jan 2008

AstraZeneca submits sNDAs for SEROQUEL XR for bipolar symptoms

AstraZeneca has announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder.

3 Jan 2008

Constipation most common cause of children's abdominal pain

A new study led by a University of Iowa researcher showed that acute and chronic constipation together accounted for nearly half of all cases of acute abdominal pain in children treated at one hospital.

18 Dec 2007

Constipation News and Research

Latest Constipation News and Research

Antidepressant amitriptyline shown to alleviate symptoms of irritable bowel syndrome

FDA approves Amitiza for irritable bowel syndrome with constipation

FDA approves Relistor for opioid-induced constipation - helps reduce effects of drugs like morphine on bowel function

Black women less likely to develop urinary incontinence than white women

Dopamine agonists reduce motor complications in Parkinson's disease, but increase other side-effects

Myth about drinking copius amounts of water debunked

Smell impairment can precede the development of Parkinson's disease in men

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

FDA approves Aloxi injection for prevention of postoperative nausea and vomiting

FDA approves PRISTIQ for the treatment of adult patients with major depressive disorder

New blood test for early stage ovarian cancer

Real-time imaging device may improve surgery for congenital colon disease

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

Lilly knocked back by FDA on Zyprexa for schizophrenia treatment

FDA approves Nexium for gastroesophageal reflux disease in children

Brain response differences found in way women with irritable bowel syndrome deal with pain

Researchers establish risk factors for Parkinson's disease

Placebo better than antipsychotic drugs for treating aggression in the intellectually disabled

AstraZeneca submits sNDAs for SEROQUEL XR for bipolar symptoms

Constipation most common cause of children's abdominal pain

Pharmaceutical Manufacturing - Industry Focus eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Constipation News and Research

Latest Constipation News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in